US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 27.440
  • -0.450-1.61%
Close Nov 29 13:00 ET
  • 26.737
  • -0.703-2.56%
Post 17:02 ET
1.82BMarket Cap-10635P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
110.35%3.19M
832.09%2.5M
-83.87%156K
192.02%6.88M
156.11%4.13M
272.73%1.52M
64.42%268K
455.75%967K
-49.32%2.36M
382.93%1.61M
Operating revenue
110.35%3.19M
832.09%2.5M
-83.87%156K
192.02%6.88M
156.11%4.13M
272.73%1.52M
64.42%268K
455.75%967K
-49.32%2.36M
382.93%1.61M
Cost of revenue
Gross profit
Operating expense
29.38%55.32M
45.83%48.82M
21.91%40.76M
36.06%148.93M
33.09%39.26M
52.14%42.76M
20.04%33.47M
39.52%33.44M
48.31%109.45M
41.01%29.5M
Selling and administrative expenses
22.30%10.05M
26.41%9.13M
37.09%9.1M
13.68%30.91M
33.84%8.83M
25.88%8.22M
0.94%7.22M
-3.92%6.64M
32.74%27.2M
5.74%6.6M
-General and administrative expense
22.30%10.05M
26.41%9.13M
37.09%9.1M
13.68%30.91M
33.84%8.83M
25.88%8.22M
0.94%7.22M
-3.92%6.64M
32.74%27.2M
5.74%6.6M
Research and development costs
31.06%45.26M
51.18%39.69M
18.15%31.66M
43.46%118.01M
32.87%30.43M
60.09%34.54M
26.63%26.25M
57.12%26.8M
54.30%82.26M
56.01%22.9M
Operating profit
-26.40%-52.13M
-39.49%-46.32M
-25.06%-40.61M
-32.63%-142.04M
-25.97%-35.13M
-48.90%-41.24M
-19.78%-33.21M
-36.47%-32.47M
-54.88%-107.1M
-35.46%-27.89M
Net non-operating interest income expense
Other net income (expense)
235.85%10.01M
287.53%10.48M
150.80%7.8M
111.72%613K
-685.05%-8.18M
226.64%2.98M
132.64%2.7M
318.57%3.11M
-228.87%-5.23M
219.91%1.4M
Gain on sale of security
235.85%10.01M
287.53%10.48M
150.80%7.8M
350.77%13.11M
209.08%4.32M
226.64%2.98M
589.54%2.7M
1,402.42%3.11M
476.04%2.91M
628.13%1.4M
Special income (charges)
----
----
----
-53.60%-12.5M
----
----
----
----
-288.45%-8.14M
--0
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
-388.40%-6.86M
--0
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
-16.67%12.5M
----
----
----
----
--15M
--0
Income before tax
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-58.79%-112.33M
-31.46%-26.49M
Income tax
0
0
Net income
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
Net income continuous Operations
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
Minority interest income
Net income attributable to the parent company
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
Basic earnings per share
20.99%-0.64
16.92%-0.54
9.68%-0.56
-21.67%-2.92
-50.00%-0.84
-42.11%-0.81
15.58%-0.65
-26.53%-0.62
-46.34%-2.4
-30.23%-0.56
Diluted earnings per share
20.99%-0.64
16.92%-0.54
9.68%-0.56
-21.67%-2.92
-50.00%-0.84
-42.11%-0.81
15.58%-0.65
-26.53%-0.62
-46.34%-2.4
-30.23%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 110.35%3.19M832.09%2.5M-83.87%156K192.02%6.88M156.11%4.13M272.73%1.52M64.42%268K455.75%967K-49.32%2.36M382.93%1.61M
Operating revenue 110.35%3.19M832.09%2.5M-83.87%156K192.02%6.88M156.11%4.13M272.73%1.52M64.42%268K455.75%967K-49.32%2.36M382.93%1.61M
Cost of revenue
Gross profit
Operating expense 29.38%55.32M45.83%48.82M21.91%40.76M36.06%148.93M33.09%39.26M52.14%42.76M20.04%33.47M39.52%33.44M48.31%109.45M41.01%29.5M
Selling and administrative expenses 22.30%10.05M26.41%9.13M37.09%9.1M13.68%30.91M33.84%8.83M25.88%8.22M0.94%7.22M-3.92%6.64M32.74%27.2M5.74%6.6M
-General and administrative expense 22.30%10.05M26.41%9.13M37.09%9.1M13.68%30.91M33.84%8.83M25.88%8.22M0.94%7.22M-3.92%6.64M32.74%27.2M5.74%6.6M
Research and development costs 31.06%45.26M51.18%39.69M18.15%31.66M43.46%118.01M32.87%30.43M60.09%34.54M26.63%26.25M57.12%26.8M54.30%82.26M56.01%22.9M
Operating profit -26.40%-52.13M-39.49%-46.32M-25.06%-40.61M-32.63%-142.04M-25.97%-35.13M-48.90%-41.24M-19.78%-33.21M-36.47%-32.47M-54.88%-107.1M-35.46%-27.89M
Net non-operating interest income expense
Other net income (expense) 235.85%10.01M287.53%10.48M150.80%7.8M111.72%613K-685.05%-8.18M226.64%2.98M132.64%2.7M318.57%3.11M-228.87%-5.23M219.91%1.4M
Gain on sale of security 235.85%10.01M287.53%10.48M150.80%7.8M350.77%13.11M209.08%4.32M226.64%2.98M589.54%2.7M1,402.42%3.11M476.04%2.91M628.13%1.4M
Special income (charges) -------------53.60%-12.5M-----------------288.45%-8.14M--0
-Less：Restructuring and merger&acquisition --------------0-----------------388.40%-6.86M--0
-Less:Impairment of capital assets --------------0------------------0----
-Less:Other special charges -------------16.67%12.5M------------------15M--0
Income before tax -10.09%-42.12M-17.51%-35.84M-11.74%-32.81M-25.91%-141.43M-63.50%-43.31M-42.85%-38.26M15.28%-30.5M-27.38%-29.36M-58.79%-112.33M-31.46%-26.49M
Income tax 00
Net income -10.09%-42.12M-17.51%-35.84M-11.74%-32.81M-25.91%-141.43M-63.50%-43.31M-42.85%-38.26M15.28%-30.5M-27.38%-29.36M-59.30%-112.33M-31.46%-26.49M
Net income continuous Operations -10.09%-42.12M-17.51%-35.84M-11.74%-32.81M-25.91%-141.43M-63.50%-43.31M-42.85%-38.26M15.28%-30.5M-27.38%-29.36M-59.30%-112.33M-31.46%-26.49M
Minority interest income
Net income attributable to the parent company -10.09%-42.12M-17.51%-35.84M-11.74%-32.81M-25.91%-141.43M-63.50%-43.31M-42.85%-38.26M15.28%-30.5M-27.38%-29.36M-59.30%-112.33M-31.46%-26.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.09%-42.12M-17.51%-35.84M-11.74%-32.81M-25.91%-141.43M-63.50%-43.31M-42.85%-38.26M15.28%-30.5M-27.38%-29.36M-59.30%-112.33M-31.46%-26.49M
Basic earnings per share 20.99%-0.6416.92%-0.549.68%-0.56-21.67%-2.92-50.00%-0.84-42.11%-0.8115.58%-0.65-26.53%-0.62-46.34%-2.4-30.23%-0.56
Diluted earnings per share 20.99%-0.6416.92%-0.549.68%-0.56-21.67%-2.92-50.00%-0.84-42.11%-0.8115.58%-0.65-26.53%-0.62-46.34%-2.4-30.23%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data